Fireside

Olema Oncology to Participate in Upcoming Investor Conferences

Retrieved on: 
Dienstag, Februar 6, 2024

SAN FRANCISCO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will participate in the following upcoming investor conferences:

Key Points: 
  • SAN FRANCISCO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will participate in the following upcoming investor conferences:
    Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a virtual Fireside Chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024, at 10:40 a.m.
  • Shane Kovacs, Chief Operating Officer, will participate in a panel discussion on Breast & Lung Cancer at TD Cowen’s 44th Annual Health Care Conference at the Marriott Copley Place in Boston, MA, on Wednesday, March 6, 2024, at 9:10 a.m.
  • Olema management will attend the Jefferies Biotech on the Bay Summit in Miami, FL, on Tuesday, March 12, 2024.
  • A live webcast of the Fireside Chat and panel and any accompanying presentation materials will be available under the News & Events section of Olema’s investor relations website at ir.olema.com .

The 17th Asian Financial Forum concludes successfully

Retrieved on: 
Donnerstag, Januar 25, 2024

HONG KONG, Jan 25, 2024 - (ACN Newswire) - The 17th Asian Financial Forum (AFF), jointly organised by the Hong Kong Special Administrative Region (HKSAR) Government and Hong Kong Trade Development Council (HKTDC), successfully concluded today, attracting over 3,600 financial and business elites from more than 50 countries and regions, including over 70 overseas and Mainland China delegations.

Key Points: 
  • HONG KONG, Jan 25, 2024 - (ACN Newswire) - The 17th Asian Financial Forum (AFF), jointly organised by the Hong Kong Special Administrative Region (HKSAR) Government and Hong Kong Trade Development Council (HKTDC), successfully concluded today, attracting over 3,600 financial and business elites from more than 50 countries and regions, including over 70 overseas and Mainland China delegations.
  • In just two days, the Forum arranged over 700 one-on-one meetings, successfully connecting investors with project owners and exploring opportunities for industry and investment cooperation.
  • Over the two-day physical event, the AFF brought together more than 140 policymakers, international financial and multilateral organisation representatives, financial institutions and corporate leaders from around the world as speakers.
  • These experiences allowed forum guests to feel at home and appreciate the vibrancy and diversity of Hong Kong.

FinovateEurope 2024: The Future of Fintech Unveiled with 35+ Live Demos and 100+ Expert Speakers

Retrieved on: 
Mittwoch, Januar 24, 2024

FinovateEurope 2024 is meticulously designed to deliver a high density of expert insights, create environments conducive to effective networking, and optimize agendas for business efficiency.

Key Points: 
  • FinovateEurope 2024 is meticulously designed to deliver a high density of expert insights, create environments conducive to effective networking, and optimize agendas for business efficiency.
  • The event will bring together over 1000 innovators, with 500 attendees from banks and financial institutions.
  • The event is supported by Finovate’s state-of-the-art networking tool, optimizing the experience for attendees seeking to redefine the future of financial services.
  • To view the list of speakers and the detailed agenda for both days, visit https://informaconnect.com/finovateeurope/agenda/2/
    To register for the in-person event, visit https://informaconnect.com/finovateeurope/purchase/select-package/

EmpowerHER: A new professional network for female leaders in health launches

Retrieved on: 
Mittwoch, Januar 24, 2024

OTTAWA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The EmpowerHER Leadership Network proudly unveils its innovative networking platform, marking a transformative milestone in championing and supporting women within Canadian health care.

Key Points: 
  • OTTAWA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The EmpowerHER Leadership Network proudly unveils its innovative networking platform, marking a transformative milestone in championing and supporting women within Canadian health care.
  • Designed collaboratively by Jennifer Stewart, President and CEO of Syntax Strategic, and Emily Gruenwoldt, CEO of Children’s Healthcare Canada, EmpowerHER is a five-part hybrid learning series, designed to establish a vibrant, dynamic community of courageous female leaders in health committed to fostering professional growth, leading change and celebrating accomplishments.
  • "EmpowerHER is about building a lasting community where women feel empowered, supported and equipped to thrive in their careers," said Jennifer Stewart.
  • Emily Gruenwoldt, CEO of Children’s Healthcare Canada, emphasized, "The EmpowerHER Leadership Series convenes female leaders in health committed to advancing their professional roles, while contributing to meaningful and sustainable change in health systems serving Canadians.

Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference

Retrieved on: 
Mittwoch, Januar 17, 2024

FOSTER CITY, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that Guo-Liang Yu, Ph.D., Chairman and Chief Executive Officer of Apollomics, and Sanjeev Redkar, Ph.D., President of Apollomics, will participate in a Fireside Chat at the B. Riley Securities 2024 Virtual Oncology Conference on Thursday, January 18, 2024 at 11:00 a.m.

Key Points: 
  • FOSTER CITY, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that Guo-Liang Yu, Ph.D., Chairman and Chief Executive Officer of Apollomics, and Sanjeev Redkar, Ph.D., President of Apollomics, will participate in a Fireside Chat at the B. Riley Securities 2024 Virtual Oncology Conference on Thursday, January 18, 2024 at 11:00 a.m.
  • ET.
  • To access the live webcast of the fireside chat, please contact your B. Riley Securities sales representative.

Driving the Future: Public Policy Discussions at Washington, D.C. Auto Show

Retrieved on: 
Freitag, Januar 5, 2024

Known on the auto circuit as the official “Public Policy Show”, the 10-day consumer show is preceded by the Public Policy Day on Thursday, January 18.

Key Points: 
  • Known on the auto circuit as the official “Public Policy Show”, the 10-day consumer show is preceded by the Public Policy Day on Thursday, January 18.
  • One of this year’s event's highlights is an Auto Caucus Roundtable featuring U.S.
  • Dingell, a prominent figure from Michigan's 6th Congressional District, paves the way to resolve clean energy issues and is dedicated to fortifying the American auto industry.
  • These discussions provide a platform to understand and adapt to the evolving industry landscape and the legislation shaping it.

Global leaders and Nobel laureate attend AFF 2024

Retrieved on: 
Dienstag, Dezember 19, 2023

Luanne Lim, Chairperson of the AFF Steering Committee and Chief Executive, Hong Kong, of HSBC, said: "The theme of the upcoming AFF is Multilateral Cooperation for a Shared Tomorrow.

Key Points: 
  • Luanne Lim, Chairperson of the AFF Steering Committee and Chief Executive, Hong Kong, of HSBC, said: "The theme of the upcoming AFF is Multilateral Cooperation for a Shared Tomorrow.
  • AFF aims to bring together influential speakers and thought leaders from across the globe to facilitate exchanges between nations and regions.
  • During the first keynote luncheon on 24 January, he will explore the post-pandemic global economic environment, analyse the latest recovery trends and emphasise the crucial role of global cooperation in sustainable development.
  • In response to ever-changing dynamics in the global economy and investment appetite, this year's AFF will introduce discussion sessions in accordance with market opportunities and industry trends.

Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine

Retrieved on: 
Dienstag, Dezember 19, 2023

HANOVER, MD, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the safety and efficacy for more cancer patients, provides an interim analysis from its Phase 1b study of its Next Generation Capecitabine (NGC-Cap).

Key Points: 
  • We are encouraged to be near completion of the Phase 1b trial as we make preparations for a subsequent Phase 2 trial with NGC-Cap,” said David Young, Pharm.D., Ph.D., President of Research and Development at Processa.
  • “We are very encouraged with the interim results from the Phase 1b trial.” added Dr. Young.
  • It is believed that NGC-Cap’s ability to inhibit the production of catabolites like FBAL is key to the success of NGC-Cap.
  • Content from the Fireside Chat will be archived through June 20, 2024.

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

Retrieved on: 
Mittwoch, November 29, 2023

FOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that members of management will be participating in a fireside chat at the JMP Securities Hematology and Oncology Summit.

Key Points: 
  • FOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that members of management will be participating in a fireside chat at the JMP Securities Hematology and Oncology Summit.
  • Details are as follows:
    A live webcast of the Fireside Chat will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com .
  • A replay of the webcast will be archived on Terns’ website for at least 30 days following the presentation.

Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Retrieved on: 
Mittwoch, November 29, 2023

FOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that Guo-Liang Yu, Ph.D., Co-Founder and Chief Executive Officer of Apollomics and Sanjeev Redkar, Ph.D., Co-Founder and President, will participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference on Wednesday, December 6, 2023 at 11:30 a.m.

Key Points: 
  • FOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that Guo-Liang Yu, Ph.D., Co-Founder and Chief Executive Officer of Apollomics and Sanjeev Redkar, Ph.D., Co-Founder and President, will participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference on Wednesday, December 6, 2023 at 11:30 a.m.
  • ET.
  • Investors interested in arranging a meeting with the Company’s management during the conference should contact the H.C. Wainwright conference coordinator.
  • A webcast link of the presentation can be accessed here , and an archived replay of the presentation will be available for 90 days following the event, under the Investors tab of the Apollomics website at https://www.apollomicsinc.com .